TAFINLAR – dabrafenib 50 mg and 75 mg capsule

Novartis Pharmaceuticals Corp

malignant melanoma with BRAF V600E mutation; malignancy; malignant melanoma with BRAF V600K mutation; malignant solid tumor with BRAF V600E mutation; non-small cell lung cancer with BRAF V600E mutation; anaplastic thyroid carcinoma with BRAF V600E mutation; high grade glioma with BRAF V600E mutation; low grade glioma with BRAF V600E mutation

Controlled Room Temp (20-25°C)